Warner-Lambert Company gift creates bioinformatics program

ANN ARBOR---The University of Michigan will receive $5 million from the Parke Davis Pharmaceutical Research Division of Warner-Lambert Company to help the University establish a new Program in Bioinformatics. This interdisciplinary program will offer graduate education and support pilot research studies in the emerging scientific field of bioinformatics, one of the areas highlighted in the U-M's Life Sciences Initiative.

The Warner-Lambert investment matches the U-M Health System's commitment, announced in October 1998 by Executive Vice President for Medical Affairs Gilbert S. Omenn, M.D., Ph.D. Computers, staff support, a classroom and new research laboratories will be located in the U-M Medical School.

Bioinformatics merges recent advances in molecular biology and genetics with advanced computer science technology. The goal is increased understanding of the complex web of interactions linking the individual components of a living cell to the integrated behavior of the whole organism.

"We are very pleased that the U-M is willing to begin a graduate level education and research program in this important area," said Wendell Wierenga, Ph.D., senior vice president for Worldwide Pre-Clinical Research, Development and Technologies for the Parke Davis Pharmaceutical Research Division of Warner-Lambert. "Bioinformatics incorporates many disciplines and specialties and requires a unique cross-training environment. Trained scientists in this area are essential to accomplishing our goal of discovering and developing novel drugs from gene to target to patient in the next decade. The opportunity to do this collaboratively with the University will benefit all of us immensely."

"This partnership with our colleagues at Warner-Lambert/Parke Davis is part of a broad relationship between the company and the University," said Omenn. "It reflects our mutual recognition of the growing importance of research and education in this rapidly developing field of sci

Contact: Sally Pobojewski
University of Michigan

Page: 1 2 3

Related biology news :

1. Ferr-Damar wins 2004 Eli Lilly and Company Research Award
2. Open access initiative from the Company of Biologists
3. ESA Corporate Award winner 2001: Weyerhaeuser Company Limited British Columbia Coastal Forest Project Team
4. SFU Spin-Off Company To Research Promising Antibacterial Agents
5. New Company Formed Through Licensing Of Cardiac-Hypertrophy Technology From Texas Institutions
6. Move Over, Protein Kinase C, Youve Got Company: Munc13-1 Is A Novel Diacylglycerol Target That Modulates Neurotransmitter Release
7. Perkin-Elmer, Dr. J. Craig Venter, And TIGR Announce Formation Of New Genomics Company
8. New Company To Turn UNC-CH, Army Inventions Into Improved Vaccines
9. Florida Company Using ORNL Technology For Revolutionary Wheelchair
10. UAB creates the first Internet server to search for genetic diversity
11. ORNL nanoprobe creates world of new possibilities

Post Your Comments:

(Date:10/10/2019)... ... October 09, 2019 , ... Calcium & Bone Health Institute ... in Vancouver, Canada on September 23-24 for two days. The purpose of symposium ... healthy bone and to prevent calcium-related diseases. The theme of this year was ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... National Research Council of Canada (NRC) to create the Laboratory of Industrial ... and in manufacturing, LIFT will offer a competitive capacity to accelerate the ...
(Date:10/8/2019)... ... October 07, 2019 , ... ... of imaging modalities such as optical projection tomography, optical coherence tomography, echocardiogram, light ... to generate these data sets inhouse, a lot of research groups struggle with ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... 2019 , ... Cheyenne is a beautiful and strong Quarter Horse and a ... Rebel’s Run , which offers riding lessons and trail riding in Afton, Virginia. ... Mimi describes her as her “go to horse.” Thus, you can imagine ...
(Date:10/3/2019)... BOSTON (PRWEB) , ... October 03, 2019 , ... Yesterday, ... 2-3, Asymmetrex founder and director, James L. Sherley, M.D., Ph.D., discussed important ... To an attendee audience including both developers and suppliers of clinical trials, in ...
(Date:9/24/2019)... ... September 24, 2019 , ... Personalized ... training and site qualification for clinical trial sites and physician investigators. The ... potential clinical trial participants. , Clinical trial sites are currently located in San ...
(Date:9/17/2019)... , ... September 17, 2019 , ... Tucker, a Labrador ... only four months old, Tucker was limping and lame on his right hip and ... dysplasia and it was called “the worst case the vet had seen.” He was ...
Breaking Biology Technology:
Cached News: